Protective effect of dehydroepiandrosterone against copper-induced lipid peroxidation in the rat

Free Radical Biology and Medicine

Volumn 22, Issue 7, 1997, Pages 1289-1294

  Boccuzzi, Giuseppe ^a   Aragno, Manuela ^a   Seccia, Milfred ^a   Brignardello, Enrico ^a   Tamagno, Elena ^a   Albano, Emanuele ^a   Danni, Oliviero ^a   Bellomo, Giorgio ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Dehydroepiandrosterone; LDL; Lipid peroxidation; Rat

Indexed keywords

ANTIOXIDANT; COPPER; COPPER SULFATE; LOW DENSITY LIPOPROTEIN; OXYGEN RADICAL; PRASTERONE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; BRAIN MICROSOME; CELL PROTECTION; CONTROLLED STUDY; DOSE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; LIVER MICROSOME; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TISSUE INJURY;

ANIMALS; ANTIOXIDANTS; BRAIN; COPPER; DEHYDROEPIANDROSTERONE; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MALE; MICROSOMES; MICROSOMES, LIVER; RATS; RATS, WISTAR;

ANIMALIA;

EID: 0030899744     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(96)00543-6     Document Type: Article

References (27)

1. Orentreich N., Brind J. L., Vogelman J. H., Andres R., Baldwin H. Long-term longitudinal measurements of plasma dehydroepiandrosterone sulphate in normal man. J. Clin. Endocrinol. Metab. 75:1992;1002-1004.
2. Zumoff B., Rosenfeld R. S., Strain G. W., Levin J., Fukushima D. K. Sex difference in twenty-four hour mean plasma concentrations of dehydroepiandrosterone sulfate (DHAS) and the DHA to DHAS ratio in normal adults. J. Clin. Endocrinol. Metab. 51:1980;330-333.
3. Boccuzzi G., Brignardello E., Di Monaco M., Gatto V., Leonardi L., Pizzini A., Gallo M. 5-En-androstene- 3β , 17β -diol inhibits the growth of MCF-7 breast cancer cells when estrogen receptors are blocked by estradiol. Br. J. Cancer. 70:1994;1035-1039.
4. Eberling P., Koivisto V. A. Physiological importance of dehydroepiandrosterone. Lancet. 343:1994;1479-1481.
5. Tannen R. H., Schwartz A. G. Reduced weight gain and delay of Coombs positive hemolytic anemia in NZB mice treated with dehydroepiandrosterone. Fed. Proc. 42:1982;464-466.
6. Gordon G. B., Bush D. E., Weisman H. F. Reduction of atherosclerosis by administration of DHEA. J. Clin. Invest. 82:1988;712-720.
7. Barrett-Connor E., Khaw K. T., Yen S. S. C. A prospective study of dehydroepiandrosterone sulphate, mortality and cardio-vascular disease. N. Engl. J. Med. 315:1986;1519-1524.
8. Coleman D. L., Leiter E. H., Schwizer R. W. Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice. Diabetes. 31:1982;830-833.
9. vy/amice by dehydroepiandrosterone. Lipids. 12:1977;409-413.
10. Schwartz O. Inhibition of spontaneous breast cancer formation in female C3H(Avy/a) mice by long-term treatment with dehydroepiandrosterone. Cancer Res. 39:1979;1129-1132.
11. Boccuzzi G., Aragno M., Brignardello E., Tamagno E., Conti G., Di Monaco M., Racca S., Danni O., Di Carlo F. Opposite effects of dehydroepiandrosterone on the growth of 7,12-dimethil-benz(a) antracene-induced rat mammary carcinomas. Anticancer Res. 12:1992;1479-1484.
12. Lucas J. A., Ahmed S. A., Casey L. M., MacDonald P. C. Prevention autoantibody formation and prolonged survival in New Zealand Black/New Zealand White F1mice fed dehydroepiandrosterone. J. Clin. Invest. 75:1985;2091-2093.
13. Schauer J. E., Shelin A., Hanson P., Stratman F. W. Dehydroepiandrosterone a beta-agonist, energy trasducers, alter antioxidant enzyme systems: Influence of chronic training and acute exercice in rats. Arch. Biochem. Biophys. 283:1990;503-511.
14. Rom W. N., Harkin T. Dehydroepiandrosterone inhibits the spontaneous release of superoxide radical by alveolar macrophages in vitro in asbestosis. Environ. Res. 55:1991;145-156.
15. Aragno M., Tamagno E., Boccuzzi G., Brignardello E., Chiarpotto E., Pizzini A., Danni O. Dehydro-epiandrosterone pretreatment protects rats against the pro-oxidant and necrogenic effects of carbon tetrachloride. Biochem. Pharmacol. 46:1993;1689-1694.
16. Aragno M., Tamagno E., Poli G., Boccuzzi G., Brignardello E., Danni O. Prevention of carbon tetrachloride-induced lipid peroxidation in liver microsomes from dehydroepiandrosterone-pretreated rats. Free Radic. Res. 21:1994;427-435.
17. Pfeifer P. M., McCay P. B. Reduced triphosphopyridine nucleotide oxidase catalyzed alterations of membrane phospholipids. J. Biol. Chem. 246:1971;6401-6408.
18. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
19. Slater T. F., Sawyer B. C. The stimulatory effects of carbon tetrachloride and other halogenoalkanes on peroxidative reactions in rat liver fractions in vitro. I. General features on systems used. Biochem. J. 123:1971;805-814.
20. Esterbauer H., Striegl G., Puhl H., Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic. Res. Commun. 6:1989;67-75.
21. Esterbauer H., Gebicki J., Puhl H., Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modifications of LDL. Free Radic. Biol. Med. 13:1992;341-390.
22. Boccuzzi G., Brignardello E., Massobrio M., Bonino L. Breast duct fluid dehydroepiandrosterone sulphate in fibrocystic disease. Eur. J. Cancer. Clin. Oncol. 23:1987;1099-1102.
23. Kask E. 17-Ketosteroids and arteriosclerosis. Angiology. 10:1959;358-368.
24. Nestler J. E., Barlascini C. O., Clore J. N., Blackard W. G. Dehydroepiandrosterone reduces serum low density lipoprotein levels and body fat but does not alter insulin sensivity in normal man. J. Clin. Endocrinol. Metab. 66:1988;57-61.
25. Palinski W., Rosenfeld M. E., Yla-Herttuala S., Gurtner G. C., Socher S. S., Butler S. W., Parthasarathy S., Carew T. E., Steinberg D., Witzum J. L. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA. 86:1989;1046-1050.
26. Bellomo G., Maggi E., Palladini G., Taddei F., Seccia M., Finardi G. Diagnostic criteria in investigating lipoprotein oxidation. Bellomo G., Finardi G., Maggi E., Rice-Evans C. Free radicals, lipoprotein oxidation and atherosclerosis. 1995;263-286 Richelieu Press, London.
27. Berliner J. A., Territo M. C., Sevanian A., Ramin S., Kim J. A., Ramshad B., Esterson M., Fogelman A. M. Minimally modified low-density lipoprotein stimulates monocyte endothelial interactions. J. Clin. Invest. 85:1990;1260-1266.